572 related articles for article (PubMed ID: 19752240)
1. Targeting NF-kappa B with a natural triterpenoid alleviates skin inflammation in a mouse model of psoriasis.
Wang H; Syrovets T; Kess D; Büchele B; Hainzl H; Lunov O; Weiss JM; Scharffetter-Kochanek K; Simmet T
J Immunol; 2009 Oct; 183(7):4755-63. PubMed ID: 19752240
[TBL] [Abstract][Full Text] [Related]
2. Antiinflammatory and antiatherogenic effects of the NF-kappaB inhibitor acetyl-11-keto-beta-boswellic acid in LPS-challenged ApoE-/- mice.
Cuaz-Pérolin C; Billiet L; Baugé E; Copin C; Scott-Algara D; Genze F; Büchele B; Syrovets T; Simmet T; Rouis M
Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):272-7. PubMed ID: 18032778
[TBL] [Abstract][Full Text] [Related]
3. Avarol inhibits TNF-alpha generation and NF-kappaB activation in human cells and in animal models.
Amigó M; Payá M; Braza-Boïls A; De Rosa S; Terencio MC
Life Sci; 2008 Jan; 82(5-6):256-64. PubMed ID: 18177902
[TBL] [Abstract][Full Text] [Related]
4. JAK3 inhibition significantly attenuates psoriasiform skin inflammation in CD18 mutant PL/J mice.
Chang BY; Zhao F; He X; Ren H; Braselmann S; Taylor V; Wicks J; Payan DG; Grossbard EB; Pine PR; Bullard DC
J Immunol; 2009 Aug; 183(3):2183-92. PubMed ID: 19596999
[TBL] [Abstract][Full Text] [Related]
5. NF-kappaB and inflammation in genetic disease.
Sebban H; Courtois G
Biochem Pharmacol; 2006 Oct; 72(9):1153-60. PubMed ID: 16965764
[TBL] [Abstract][Full Text] [Related]
6. Molecular imaging of the transcription factor NF-kappaB, a primary regulator of stress response.
Carlsen H; Alexander G; Austenaa LM; Ebihara K; Blomhoff R
Mutat Res; 2004 Jul; 551(1-2):199-211. PubMed ID: 15225593
[TBL] [Abstract][Full Text] [Related]
7. Nature of cell kinetics in psoriatic epidermis.
Doger FK; Dikicioglu E; Ergin F; Unal E; Sendur N; Uslu M
J Cutan Pathol; 2007 Mar; 34(3):257-63. PubMed ID: 17302610
[TBL] [Abstract][Full Text] [Related]
8. Thymulin and zinc (Zn2+)-mediated inhibition of endotoxin-induced production of proinflammatory cytokines and NF-kappaB nuclear translocation and activation in the alveolar epithelium: unraveling the molecular immunomodulatory, anti-inflammatory effect of thymulin/Zn2+ in vitro.
Haddad JJ
Mol Immunol; 2009 Dec; 47(2-3):205-14. PubMed ID: 19850345
[TBL] [Abstract][Full Text] [Related]
9. NF-kappaB is involved in inhibition of lipoxin A4 on dermal inflammation and hyperplasia induced by mezerein.
Wu SH; Liu B; Dong L; Wu HJ
Exp Dermatol; 2010 Aug; 19(8):e286-8. PubMed ID: 20100194
[TBL] [Abstract][Full Text] [Related]
10. Anti-psoriatic drug anthralin activates transcription factor NF-kappa B in murine keratinocytes.
Schmidt KN; Podda M; Packer L; Baeuerle PA
J Immunol; 1996 Jun; 156(11):4514-9. PubMed ID: 8666828
[TBL] [Abstract][Full Text] [Related]
11. Reduction of CD18 promotes expansion of inflammatory γδ T cells collaborating with CD4+ T cells in chronic murine psoriasiform dermatitis.
Gatzka M; Hainzl A; Peters T; Singh K; Tasdogan A; Wlaschek M; Scharffetter-Kochanek K
J Immunol; 2013 Dec; 191(11):5477-88. PubMed ID: 24190659
[TBL] [Abstract][Full Text] [Related]
12. PPARgamma inhibits NF-kappaB-dependent transcriptional activation in skeletal muscle.
Remels AH; Langen RC; Gosker HR; Russell AP; Spaapen F; Voncken JW; Schrauwen P; Schols AM
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E174-83. PubMed ID: 19417127
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept.
Lizzul PF; Aphale A; Malaviya R; Sun Y; Masud S; Dombrovskiy V; Gottlieb AB
J Invest Dermatol; 2005 Jun; 124(6):1275-83. PubMed ID: 15955104
[TBL] [Abstract][Full Text] [Related]
14. Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes.
Kanda N; Shibata S; Tada Y; Nashiro K; Tamaki K; Watanabe S
Eur J Immunol; 2009 Apr; 39(4):996-1006. PubMed ID: 19350575
[TBL] [Abstract][Full Text] [Related]
15. Naturally occurring antioxidant nutrients reduce inflammatory response in mice.
Novoselova EG; Lunin SM; Novoselova TV; Khrenov MO; Glushkova OV; Avkhacheva NV; Safronova VG; Fesenko EE
Eur J Pharmacol; 2009 Aug; 615(1-3):234-40. PubMed ID: 19463810
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of survivin and NF-kappaB in psoriasis, an immunohistochemical study.
Abdou AG; Hanout HM
J Cutan Pathol; 2008 May; 35(5):445-51. PubMed ID: 18005174
[TBL] [Abstract][Full Text] [Related]
17. Xanthohumol inhibits IL-12 production and reduces chronic allergic contact dermatitis.
Cho YC; You SK; Kim HJ; Cho CW; Lee IS; Kang BY
Int Immunopharmacol; 2010 May; 10(5):556-61. PubMed ID: 20144742
[TBL] [Abstract][Full Text] [Related]
18. Antigen-specific suppression of established arthritis in mice by dendritic cells deficient in NF-kappaB.
Martin E; Capini C; Duggan E; Lutzky VP; Stumbles P; Pettit AR; O'Sullivan B; Thomas R
Arthritis Rheum; 2007 Jul; 56(7):2255-66. PubMed ID: 17599748
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory effects of plumbagin are mediated by inhibition of NF-kappaB activation in lymphocytes.
Checker R; Sharma D; Sandur SK; Khanam S; Poduval TB
Int Immunopharmacol; 2009 Jul; 9(7-8):949-58. PubMed ID: 19374955
[TBL] [Abstract][Full Text] [Related]
20. Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling.
Nenci A; Huth M; Funteh A; Schmidt-Supprian M; Bloch W; Metzger D; Chambon P; Rajewsky K; Krieg T; Haase I; Pasparakis M
Hum Mol Genet; 2006 Feb; 15(4):531-42. PubMed ID: 16399796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
